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The bacterium Clostridium botulinum type C produces a progenitor toxin (C16S toxin) that binds to O-linked sugar chains terminating with
sialic acid on the surface of HT-29 cells prior to internalization [A. Nishikawa, N. Uotsu, H. Arimitsu, J.C. Lee, Y. Miura, Y. Fujinaga, H. Nakada,
T. Watanabe, T. Ohyama, Y. Sakano, K. Oguma, Biochem. Biophys. Res. Commun. 319 (2004) 327–333] [21]. Based on this, it was hypothesized
that the C16S toxin is internalized via clathrin-coated pits. To examine this possibility, the internalized toxin was observed with a fluorescent
antibody using confocal laser-scanning microscopy. The confocal images clearly indicated that the C16S toxin was internalized mainly via
clathrin-coated pits and localized in early endosomes. The toxin was colocalized with caveolin-1 which is one of the components of caveolae,
however, implying the toxin was also internalized via caveolae. The confocal images also showed that the neurotoxin transported to the endosome
was transferred to the Golgi apparatus. However, the non-toxic components were not merged with the Golgi marker protein, TGN38, implying the
neurotoxin was dissociated from progenitor toxin in endosomes. These results suggested that the C16S toxin was separated to the neurotoxin and
other proteins in endosome and the neurotoxin was further transferred to the Golgi apparatus which is the center for protein sorting.
© 2005 Elsevier B.V. All rights reserved.Keywords: Botulinum toxin; Endocytosis; Mucin; Clathrin; Caveolae; HT-29 cell1. Introduction
Clostridium botulinum has been classified into seven types,
A to G, which are differentiated by the immunological
specificity of the neurotoxin (NT) produced. The molecular
masses of all types of these neurotoxins are approximately 150
kDa. In the type C strain, two different sized progenitor toxinsAbbreviations: C16S toxin, Clostridium botulinum type C progenitor toxin;
HA, hemagglutinin; NT, neurotoxin; mβ-CD, methyl-β-cyclodextrin; TGN,
trans-Golgi network
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are produced. The C12S toxin consists of a NT and a non-toxic
component having no hemagglutinin (HA) activity that is
designated as non-toxic non-HA. The C16S toxin consists of
C12S toxin and four kinds of different subcomponents (HAs):
HA1, HA2, and HA3a, and HA3b provided processing by
protease after translation of HA3. Hemagglutinin activity of
HAs was shown in previous reports [1–6].
NT is a high potent inhibitor of the neurotransmitter release
from the peripheral nerve terminus. Once localized in the
cytoplasm of nerve cells, the NT functions by specifically
cleaving one of three different SNARE proteins essential for
synaptic vesicle fusion [7,8]. The non-toxic components (non-
toxic non-HA, HA1, HA2, HA3a and HA3b) are presumed to
have the role of protecting the neurotoxin against acidity and
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adhesion in the attachment of 16S toxin to the microvilli of the
intestine of guinea pig [10]. In type A and C, HA1 and HA3b
bind to each terminal galactose and sialic acid moieties of sugar
chain [9,11]. However, the internalization pathway into
epithelial cells and its mechanism are still unknown.
Oligosaccharides are involved in a wide range of biological
processes, for example, bacterial and viral infection, cancer
metastasis, the blood-clotting cascade and many other crucial
intercellular recognition events. To express their function,
oligosaccharides occur as glycoconjugates attached to proteins
or lipids that are found on the surface of the cells [12]. Mucins
are high molecular-weight glycoproteins that consist of
oligosaccharides attached to serine or threonine residues of
the mucin core protein backbone by O-glycosidic linkages.
Mucin peptides are biosynthesized in the endoplasmic reticu-
lum (ER) and transported to the Golgi apparatus. N- and O-
glycosylated mucins are secreted into the plasma membrane via
the trans-Golgi network. Mucin on the cell surface that is not
completely glycosylated, referred to as premature mucin, is
internalized via clathrin-mediated endocytosis and again
localized in the Golgi apparatus. After further O-glycosylation,
the mucin is resecreted onto the apical membrane [13,14].
Mucins are expressed on the surface of the gastrointestinal track
in the human body to protect epithelial cells from pathogens and
digestive enzymes [15–17]. Human adenocarcinoma HT-29
cells are epithelial-like and moderately well-differentiated cells
[18] and express several kinds of mucins [19,20]. We previously
reported that the receptor on the HT-29 cell surface targeted by
the C16S toxin is an O-linked sugar chain of mucin-like
glycoproteins [21]. Therefore, it is hypothesized that the C16S
toxin is internalized with mucin-like glycoprotein via clathrin-
mediated endocytosis. This paper reports the identification of
the endocytic pathway of C16S toxin into HT-29 cells through
confocal laser-scanning microscopy using antibodies specific to
the clathrin heavy chain, EEA1 and caveolin-1. It was found
that the C16S toxin is internalized into HT-29 cells via both
clathrin-coated pits and caveolae. Furthermore, neurotoxin is
transferred to Golgi apparatus.
2. Materials and methods
2.1. Materials
Dulbecco's modified Eagle Medium (DMEM), minimum essential medium
(MEM), Dulbecco's phosphate-buffered saline (PBS), methyl-β-cyclodextrin
(mβ-CD) and transferrin were all purchased from Sigma. Bafilomycin A1 was
purchased from Wako Pure Chemical Industries (Japan). Acridine orange was
purchased from Molecular Probes. The ECL Plus Western Blotting Detection
System was obtained from Amersham Biosciences. All other chemicals were
purchased from Sigma.
2.2. Toxins and antibodies
Type C 16S toxin was prepared from the culture fluid of C. botulinum type
C strain Stockholm according to a procedure described previously [10]. Rabbit
antiserums against the type C non-toxic (anti-C non-toxic) component [22],
type C NT (anti-C ST HC) [23] and transferrin, all previously prepared, were
used. Mouse monoclonal antibody against the type C HA1 component(CHA1-489) and HA3b component (CHA3b-6) was prepared previously [24].
Rabbit polyclonal antibody against caveolin and mouse monoclonal antibody
against human clathrin heavy chain, caveolin-1 and EEA1 were purchased
from BD Transduction Laboratories. Monoclonal antibody against LAMP-1
(CD107a) was purchased from BD Bioscience Pharmingen. Monoclonal
antibody against human PDI and TGN38 were purchased from Affinity
BioReagents. Rabbit polyclonal antibody against Src-family kinases (c-Src)
was obtained from Santa Cruz Biotechnology. Tetramethylrhodamine anti-
rabbit IgG (H+L) and Alexa Fluor 488 anti-mouse IgG (H+L) were
purchased from Molecular Probes.
2.3. Cell culture
Human colon carcinoma cell line HT-29 was purchased from the American
Type Culture Collection. The cells were grown in DMEM supplemented with
10% (v/v) fetal bovine serum and 0.1 mg/ml kanamycin (FBS/DMEM) at 37 °C
in a 5% CO2 atmosphere.
2.4. Cholesterol depletion
HT-29 cells were grown in 8-well chamber slides (Nalge Nunc
International). The cells were washed twice with fresh MEM without FBS
and incubated with 10 mM mβ-CD in MEM at 37 °C for 30 min in a 5% CO2
atmosphere [25].
For the examination of endocytosis recovery, the mβ-CD-treated cells were
washed twice with fresh MEM without mβ-CD and incubated in DMEM with
10% FBS at 37 °C for 90 min in a 5% CO2 atmosphere [26].
2.5. Confocal laser-scanning microscopy
HT-29 cells grown in 8-well chamber slides were washed twice with fresh
DMEM (pH 7.0) and incubated with C16S toxin (final concentration, 40 nM) or
transferrin (final concentration, 0.017 mg/ml) in DMEM (pH 7.0) at 37 °C for 5
min in a 5% CO2 atmosphere. After incubation, the cells were immediately
washed with DMEM (pH 7.0) and incubated at 37 °C in a 5% CO2 atmosphere
for various times. The cells were then washed with PBS twice, fixed with 3.7%
formaldehyde for 15 min, quenched with 50 mM NH4Cl for 15 min, and then
permeabilized with 0.1% saponin in 2% BSA and PBS for 1 h at room
temperature. All antibodies were diluted with 0.1% saponin, 2% BSA in PBS
(dilution buffer) and incubated at room temperature. The permeabilized cells
were incubated with primary antibodies (anti-C non-toxic, anti-C ST HC, anti-
transferrin, anti-caveolin, or c-Src; diluted 1:200, CHA1-489; 1.6 mg/ml,
CHA3b-6; 2.4 mg/ml, anti-clathrin heavy chain, anti-ceveolin-1 or anti-EEA1;
25 μg/ml, anti-TGN38 and anti-PDI; diluted 1:10, anti-LAMP-1; 12.5 μg/ml)
for 1 h and washed three times with dilution buffer. The cells were then
incubated with a secondary antibody, tetramethylrhodamine-conjugated anti-
rabbit IgG (H+L) (0.01 mg/ml), for 1 h and then washed three times. After
treatment with a third antibody, Alexa Fluor 488-conjugated anti-rabbit IgG
(H+L) (0.01 mg/ml), the cells were mounted with Vectashield mounting
medium (H-1000). Confocal images were collected a lot from the top to the
bottom of the cells using a Leica TCS 4D laser-scanning confocal
microscope. The images used in this study were from the middle of the
cells.
2.6. Detection of toxin receptor by far Western blotting analysis
HT-29 cells were grown to about 90% confluency in a dish, some of
which were then treated with 10 mM mβ-CD for 30 min. After this treatment,
the cells were washed twice with PBS, harvested, and lysed on ice for 20 min
with 1% Triton X-100 in 25 mM MES buffer (pH 6.5) containing 1 mM
PMSF and 150 mM NaCl (MES buffer), followed by homogenization with a
Potter-type homogenizer. The homogenized cells were then mixed with an
equal volume of 80% sucrose. The homogenate was then overlaid with 1.5 ml
of 30% sucrose and 0.5 ml of 5% sucrose in MES buffer and centrifuged
through a step density gradient at 200,000×g for 18 h at 4 °C in a TLA-100.3
rotor (Beckman). After centrifugation, each 0.3 ml fraction was collected
from the top. The Triton X-100-soluble and -insoluble fractions were
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The separated proteins were then transferred to a PVDF membrane. The
membrane was treated with 2% bovine serum albumin dissolved in PBS for 1
h. For far Western blotting analysis, the blocked membrane was incubated
with 0.4 nM C16S toxin in PBS for 1 h, washed twice with PBS for 5 min,
and then incubated with anti-C non-toxic antiserum for 1 h. To detect the
rafts-associated Src family kinases, the membrane was soaked in an anti-c-Src
antibody solution diluted (1:200) with PBS at 4 °C for 18 h. After washing
with PBS twice, the membrane was treated with anti-rabbit Ig HRP-linked F
(ab′)2 and subjected to ECL Plus Western Blotting Detection according to the
manufacturer's instructions.
2.7. Bafilomycin A1 treatment and acridine orange
The cells grown on an 8 well chamber slide were treated at 37 °C for 1 h with
FBS/DMEM containing 1/1000 Bafilomycin A1 by volume dissolved in
dimethyl sulfoxide (The final concentration of Bafilomycin A1 was 100 nM).
For control experiments, only dimethyl sulfoxide was added to the medium
instead of the Bafilomycin A1 solution. The cells were then incubated at 37 °C
for 10 min with 10 μg/ml acridine orange in Opti-MEM I Reduced-Serum
Medium (Gibco). After washing three times with fresh medium described above,
the slides were examined using fluorescent microscopy.3. Results and discussion
3.1. The internalization of C16S toxin in HT-29 cells
Recent studies have shown that HT-29 cells have receptor
for the C16S toxin on their surfaces and have elucidated the
mechanism for the uptake of this toxin [21]. To clarify the
internalization mechanism of C16S toxin in HT-29 cells, a
double labeling method with antibodies against the toxin and
the organelle marker protein was attempted, and observed the
internalized toxin by confocal laser-scanning microscope.
C16S toxin binds to the sugar chain of mucin-like glycopro-
teins but not ganglioside on the cell surface. Since
glycoprotein mucin, MUC1, is internalized by clathrin-
mediated endocytosis [13], we have expected that C16S
toxin is internalized via the same pathway. Double labeling
with antibodies against both the clathrin heavy chain [27] and
the early endosome marker EEA1 [28] showed that the C16S
toxin was internalized via clathrin-coated pits and localized in
early endosomes (Fig. 1A). This is seen in Fig. 1A as the
yellow colored endosomes, the color of which is due to
overlap between the marker protein (green) and the toxin
(red). As shown in the upper and middle right images, the
intracellular locations of clathrin heavy chain, EEA1 and
C16S toxin were overlap well. On the other hand, in the lower
right image, there were some good merged yellow spots and
relatively lots of green and red spots, suggesting that the
intracellular caveolin-1 and C16S toxin were colocating only a
little. The same experiments using anti-C NT antiserum
instead of anti-non-toxic components antiserum were done
as show in Fig. 1B. There were no differences in results
caused by a change of antiserum. Since cholera toxin from
Vibrio cholerae is internalized via caveolae and clathrin-coated
pits [29–31], the possible internalization through caveolae was
examined using the monoclonal antibody against caveolin-1,
which is one of the components for caveolae formation and
maintenance [32]. Transferrin was used as a positive controlregarding the clathrin-coated pits [33] and early endosomes
[34], and as a negative control regarding the caveolae [35]. As
shown in Fig. 1A and B, a little amount of the C16S toxin was
localized in caveolin-1-positive endosomes, whereas no
overlap was observed in the case of transferrin (Fig. 1B).
This finding was supported by the observation of double
labeling experiments with rabbit polyclonal antibody against
Src-family kinases and caveolin. Src-family kinases associated
with the rafts domain, which is the area associated with
caveolae invagination, are used as specific marker molecules
of the domain [36]. Anti-caveolin is a polyclonal antibody
against caveolin-1, which was used to confirm the result that
C16S toxin merged with caveolin-1. The results of this double
labeling showed that an HA component of the C16S toxin,
HA1 or HA3b, colocating with raft- or caveolae-associated
proteins existed (Fig. 1C). These results strongly suggest that
the C16S toxin enters HT-29 cells via caveolae as well as
clathrin-coated pits.
3.2. The dependence of the internalization of C16S toxin on
membrane cholesterol
Cholesterol present in the plasma membrane of mammalian
cells is required for the formation and stabilization of clathrin-
coated endocytic vesicles and invaginated caveolae [37,38].
Methyl-β-cyclodextrin (mβ-CD) is a water-soluble cyclic
heptasaccharide that has been extensively used as a cho-
lesterol-depleting reagent. It was reported that the extraction
of cholesterol by mβ-CD strongly inhibited the endocytosis
of transferrin, EGF and cholera toxin [31,37]. To test whether
C16S toxin internalization in HT-29 cells is dependent on the
membrane cholesterol, cells were treated with mβ-CD as
described in Materials and methods. The results indicated that
the internalization of C16S toxin was strongly blocked by
treatment with mβ-CD, although the toxin was bound to the
cell surface (Fig. 2A). In addition, the same phenomenon was
observed for transferrin (Fig. 2B). To confirm the mβ-CD-
treated cells were still living, the mβ-CD-treated cells were
washed with medium and further incubated for 90 min. As
shown in Fig. 2C, recovery of the endocytosis mechanism
was observed upon elimination of the mβ-CD in the medium.
These results clearly indicate that cholesterol is essential for
trafficking the C16S toxin and transferrin into the HT-29
cells.
3.3. The presence of receptor glycoproteins for the C16S toxin
in rafts domains on HT-29 cells
Lipid rafts are plasma membrane microdomains enriched
with glycosphingolipids and cholesterol [39]. A number of
proteins have been found to be permanently associated with
rafts domains [40]. Cellular proteins and bacterial toxins that
bind to a molecule within a rafts domain are internalized via
caveolae inside the plasma membrane. Examples of this
mechanism include the endocytosis of GPI-anchor proteins
[33] and cholera toxin [29]. Cholera toxin binds specifically to
glycosphingolipid GM1 in rafts domains and is internalized via
Fig. 1. The initial internalization pathway of C16S toxin in HT-29 cells. (A), HT-29 cells were treated with C16S toxin at 37 °C for 5 min and then incubated in toxin-
free medium for 10 min. The bound and internalized C16S toxins were observed with confocal laser-scanning microscopy using rabbit anti-C non-toxic component
antiserum and tetramethylrhodamine anti-rabbit IgG (H+L). (B), The cells were treated with C16S toxin as the same as (A), and detected NT using rabbit anti-C NT
antiserum instead of anti-C non-toxic component antiserum (C), HT-29 cells were incubated with transferrin at 37 °C for 2 min. The cell-associated transferrin was
detected using rabbit anti-transferrin antiserum and tetramethylrhodamine anti-rabbit IgG (H+L). (D), HT-29 cells were incubated with C16S toxin at 37 °C for 5 min
and then incubated in toxin-free medium for 10 min. The HA components were detected using a mouse monoclonal antibody against the HA components and Alexa
Fluor 488 anti-mouse IgG (H+L).
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internalized via caveolae (Fig. 1), the next step in determining
more about the internalization mechanism was to establishwhether or not the receptor for C16S toxin is in a rafts domain
on the plasma membrane. As shown in Fig. 3A, the receptor
glycoproteins for C16S toxin were weakly observed in the rafts
Fig. 2. The influence of the membrane cholesterol upon the initial internalization
of C16S toxin. HT-29 cells were incubated with and without 10 mM mβ-CD at
37 °C for 30 min and then incubated with C16S toxin (A) or tansferrin (B) at 37
°C. (C), HT-29 cells were treated (+, +→−) and untreated (−) with 10 mM mβ-
CD at 37 °C for 30 min. The treated cells were further incubated with FBS/
DMEM at 37 °C for 90 min without mβ-CD (+→−). These cells were then
incubated with C16S toxin at 37 °C for 5 min and then incubated in toxin-free
medium for 10 min. The C16S toxin was detected using rabbit anti-non-toxic
components antiserum and tetramethylrhodamine anti-rabbit IgG (H+L). The
internalized toxin in these cells was observed with confocal laser-scanning
microscopy.
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the a much stronger receptor presence was observed in the non-
rafts domain (lanes 7–9). Src-family kinases are used as
biochemical markers of lipid rafts [36]. The total amounts of the
receptor glycoproteins in rafts domains (Fig. 3A lanes 2–4)
were calculated within 2% from luminescence intensity
measurement. To confirm the existence of receptors in the
rafts domains was not an artifact, HT-29 cells were treated with
mβ-CD for 30 min and then lysed with 1% Triton X-100. As
shown in Fig. 3B, the bands of the receptor glycoproteins and c-
Src were almost completely absent from the rafts fractions after
treatment with mβ-CD. Rather, all of the receptor glycoproteins
were present in the high-density fractions. This result clearly
indicates that rafts domains of the HT-29 cell membrane contain
small amounts of the receptor glycoproteins for the C16Sprogenitor toxin. C16S toxin molecules bound to receptor
glycoproteins in rafts domains may have a chance to be
internalized via caveolae. It was reported, however, that cholera
toxin associated with GM1 in rafts domains was internalized via
clathrin-coated pits as well as caveolae [31]. At this time, it is
not clear what factors determine the endocytic pathway for a
given toxin.
3.4. The transport of the NT to the Golgi apparatus
The next experiment was designed to determine whether the
C16S toxin internalized in endosomes is transported to the
Golgi apparatus or to some undetermined location. The Golgi
apparatus is the focus of this experiment based on the fact that
the C16S toxin binds to mucin-like glycoproteins and mucin are
ultimately transported to the Golgi apparatus. The Golgi
apparatus in HT-29 cells was visually detected with a
monoclonal antibody against the trans-Golgi network marker
TGN38 [41]. As shown in Fig. 4A, the non-toxic components of
C16S toxin were not transported to the TGN. Moreover, the
presence of C16S toxin in the Golgi apparatus was tested after
the cells were incubated for 30 min. This result also showed that
C16S toxin was not transported to the TGN (Fig. 4A). Given
that the antiserum used in the above experiment does not
recognize NT, the internalized toxin with antiserum against NT
was observed to further confirm that the toxin was not
transported to the Golgi apparatus. As shown in Fig. 4B, the
NT was clearly colocalized with TGN38. These results
suggested that the NT might dissociate from the C16S toxin
in HT-29 cells. Furthermore, the confocal images of the double
labeling experiment with antiserum against the NT and
monoclonal antibody against the HA1 or HA3b component
showed that the NT was dissociated from the C16S toxin after
entering the cells (Fig. 4C). However, these results are not
consistent with the transport of internalized premature mucin to
the Golgi apparatus. It is not clear why the non-toxic
components were not transported to the TGN.
It is known that other internalized bacterial toxins, cholera
toxin and the plant toxin ricin are transported to the Golgi
apparatus and to the endoplasmic reticulum (ER). These
transported toxins migrate in the cytoplasm and ultimately
cause disease [29,42,43]. Since the NT was transported to the
TGN, experiments were done to determine if it was also
transported to the ER using a monoclonal antibody against
protein disulfide isomerase, PDI [44]. The results indicated that
the components of the C16S toxin did not reach the ER, as
overlapping was not detected between the toxin components
and PDI. Many toxins from bacteria and plants invade epithelial
cells and impair cellular functions. Botulinum toxin, however,
passes through epithelial cells in the intestine and migrates into
the bloodstream. Therefore, it is expected that botulinum toxin
follows a different transport pathway from that of cholera toxin
and ricin.
The key step in this process is the point at which the NT
component of C16S toxin dissociates from the remainder of the
molecule. The NT is known to separate from C16S toxin when
the toxin is exposed to alkaline conditions (pH 8.8) and
Fig. 3. Detection of the toxin receptor by far Western blotting. HT-29 cells were incubated without (A) and with (B) 10 mMmβ-CD at 37 °C for 30 min. The cells were
lysed with 1% Triton X-100 and fractionated by sucrose density gradient ultracentrifugation. The receptor glycoproteins for the C16S toxin were detected by far
Western blotting analysis according to the methods given in Materials and methods. Mr indicates the migrated position of the standard proteins and their relative
molecular mass ×103. c-Src was used as specific marker molecules of the rafts domains [26].
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has been reported, however, that the pH value of endocytic
vesicles inside the plasma membrane was 5.5–6.5 using a pH
indicator [45,46]. Additional experiments were done over a
wider range or pH values to determine other possible points atFig. 4. The intracellular trafficking of the neurotoxin. HT-29 cells were preincubated w
min or 30 min (A). HT-29 cells were preincubated with C16S toxin at 37 °C for 5
observed with confocal laser-scanning microscopy. The non-toxic components of the
NTof C16S toxin was detected using the rabbit anti-heavy chain of NT antiserum. HA
detected using monoclonal mouse anti-CHA3b-6 antibody. TGN was detected using
mouse anti-PDI antibody.which the NT dissociation might occur. C16S toxin was
incubated in 0.1 M sodium phosphate buffer containing 150
mM NaCl solutions with different pH values (pH 5.0, 6.9, or
8.0) for 30 min, followed by gel filtration chromatography
(TSK-GEL G3000SW, TOSOH Japan) equilibrated with eachith C16S toxin at 37 °C for 5 min and then incubated in toxin-free medium for 10
min and then incubated in toxin-free medium for 10 min (B, C). All cells were
C16S toxin were detected using rabbit anti-non-toxic components antiserum. The
1 were detected using monoclonal mouse anti-CHA1-489 antibody. HA3b were
monoclonal mouse anti-TGN38 antibody. ER was detected using monoclonal
Fig. 5. Determination of final destination of the accompanying HA proteins. HT-
29 cells were treated without (A) and with (B) 100 nM bafilomycin A1 at 37 °C
for 60 min. After treatment, the cells were preincubated with C16S toxin at 37
°C for 5 min and then incubated in toxin-free medium for 10 min. The non-toxic
components of C16S toxin were detected using rabbit anti-non-toxic
components antiserum. The NT component was detected using rabbit anti-NT
HC component antiserum. (C), HT-29 cells were treated without (A) and with
(B) 100 nM bafilomycin A1 at 37 °C for 60 min. After treatment, the acidified
lysosomes in the cells were visible with acridine orange. The cells were
observed with fluorescence microscopy.
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values in this treatment (data not shown). Incubation for up to
20 h resulted in no additional dissociation, indicating that the
C16S toxin is remarkably stable in solution of pH 5.0–8.0.
These results implied that detachment of the NT from the C16S
toxin need a function of something other than an acidic
environment, for example, a conformation exchange through
binding to a receptor or hydrolysis by a protease enzyme. The
conformation of this NT is known to change at pH 4.5–5.0
lower than endosomal pH 5.5–6.5 [47]. It is not excluded the
possibility that acidic factor involves to the dissociation of NT
from C16S toxin.
3.5. The dismantlement of progenitor toxin
The data presented above indicate that the NT and the non-
toxic components of C16S toxin dissociate in endosomes, and
that only the NT is transported to the TGN (Fig. 4). The ultimate
destination of the non-toxic components is unknown. Given that
these components bind to the receptor glycoproteins during the
C16S toxin invasion into cells, there is the possibility that they
are carried to lysosomes with the internalized glycoproteins
[48,49]. This possibility was tested by using an antibody against
the lysosomal marker protein LMAP-1 [50]. As shown in Fig.
5A, the non-toxic components and the NT were not overlapped
with LAMP-1. It was, however, thought that degradation of the
non-toxic components in the lysosomes might have lead to no
overlapping. To exclude the possibility that the non-toxic
components were broken down immediately by protease
enzymes in the lysosomes, HT-29 cells were treated with 100
nM bafilomycin A1 solution at 37 °C for 60 min. This reagent
inhibits acidification and protein degradation in the lysosomes
of cells [51]. The effect of the inhibitor on acidification in the
lysosomes was checked by vital staining with acridine orange.
The fluorescence of acridine orange was green around the
nucleus and orange around the acidified lysosome prior to
treatment with bafilomycin A1, however, the orange granular
pattern was not present after treatment (Fig. 5C). The possibility
that the non-toxic components merged with LAMP-1 in the
treated cell was also examined (Fig. 5B). The result indicated
that the non-toxic components and the NT were not transported
to the lysosomes, as yellow punctate structures were not
observed in the bafilomycin A1-treated cells (Fig. 5B).
Transferrin receptor protein (TfR) has been well studied as an
endocytic protein [52]. This receptor is internalized in early
endosomes and transported to the plasma membrane via
recycling endosomes [53]. Since the non-toxic components of
C16S toxin were not transported to the Golgi apparatus or to the
lysosomes, these components may be secreted back to the
plasma membrane via recycling endosomes like TfR. This
pathway is the subject of future investigation.
In conclusion, this study found that C16S toxin was
internalized mostly via clathrin-coated pits and secondarily
via raft and localized in early endosomes. The existence of
receptor glycoproteins in rafts domains suggested that the toxin
bound to a receptor in a rafts domain was selectively
internalized via caveolae. Membrane cholesterol was importantin the internalization of this toxin. The observation that the NT
was overlapped with TGN38 indicated that the NT dissociated
from the C16S progenitor toxin inside the plasma membrane.
This study provides fundamentally important information on
the internalization pathway and on the transcytosis pathways of
the botulinum neurotoxin in cells since it is unknown
mechanism how the orally taken toxin reaches to nerve cells.
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